RE:RE:RE:RE:FDA MEETINGok, when the office of therapeutic products (otp) at the fda sent the decision to grant the type c meeting, that should have been accompanied with the meeting date.
that said and if that happened, then oncy is supposed to send a meeting package to the otp at least 47 days before the scheduled date of the meeting or wro (written request only).
the meeting is scheduled for 60 minutes.
if the meeting takes the form of a teleconference, then otc submits responses to questions in oncy's package ntl (no later than) 5 days before the scheduled meeting date and oncy is required to respond to the fda's preliminary response nlt 3 days after receipt of the fda's preliminary response.
all that said, oncy's timeline for submission of its meeting package is right about now +/- a week.
as to any obligation to inform shareholders as to any point along that timeline, i don't know. seems anything along that timeline is somewhat administrative. however, if given the green light i would think that would be material and would warrant a pr/nr
so, put a pin on your calendar for the end of june.